Page last updated: 2024-08-18

pyrroles and Cancer of Nasopharynx

pyrroles has been researched along with Cancer of Nasopharynx in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19902 (14.29)18.7374
1990's1 (7.14)18.2507
2000's3 (21.43)29.6817
2010's8 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, XT; Guo, KY; He, YJ; Huang, YX; Li, YH; Song, CY; Wu, BY1
Bruegger, DE; Hoover, L; Jones, JW; Le, T; New, J; Tawfik, O; Thomas, SM; Usman, S; Yalamanchali, S1
Huang, J; Ma, J; Mu, X; Qin, Y; Wu, G; Xu, S; Yang, K; Zhang, Z; Zhou, H1
Chan, AT; Cheng, SH; Cheung, CS; Ho, K; Hui, EP; Lau, CP; Lui, VW; Ma, BB; Ng, MH; Wong, CS1
Guo, K; He, Y; Huang, Y; Li, Y; Wang, Y1
Ahuja, AT; Chan, ATC; Chan, SL; Hui, EP; Kam, MKM; King, AD; Loong, HH; Ma, BBY; Mo, F; Zee, BCY1
Deutsch, E; Soria, JC1
Cai, Z; Chen, W; Jin, Q; Ye, X1
Chowbay, B; Lye, KY; Moore, S; Olivo, M; Sharma, A; Zhou, Q1
Mahendran, R; Pook, SH; Toh, CK1
Barrows, LR; Haughey, HM; Holden, JA; Ireland, CM; Matsumoto, SS; Schmehl, DM; Venables, DA1
Bifulco, G; Bruno, I; Casapullo, A; Cutignano, A; Debitus, C; Gomez-Paloma, L; Riccio, R1
Artico, M; Chimenti, F; Dolfini, E; Giuliano, R; Morasca, L; Vomero, S1
Artico, M; De Martino, G; Dolfini, E; Giuliano, R; Massa, S; Morasca, L; Scalzo, M1

Trials

2 trial(s) available for pyrroles and Cancer of Nasopharynx

ArticleYear
Hemorrhagic complications in a phase II study of sunitinib in patients of nasopharyngeal carcinoma who has previously received high-dose radiation.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:6

    Topics: Adult; Aged; Antineoplastic Agents; Carcinoma; Chemoradiotherapy; Epistaxis; Female; Hematemesis; Hemoptysis; Humans; Indoles; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Sunitinib; Treatment Outcome

2011
Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models.
    Cancer chemotherapy and pharmacology, 2005, Volume: 56, Issue:6

    Topics: Adenocarcinoma; Angiogenesis Inhibitors; Animals; Anthracenes; Antineoplastic Agents; Chemotherapy, Adjuvant; Drug Screening Assays, Antitumor; Gene Expression; Indoles; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Neoplasms; Neoplasm Transplantation; Neoplasms, Experimental; Oxindoles; Perylene; Photochemotherapy; Propionates; Protein-Tyrosine Kinases; Proteins; Pyrroles; Survival Rate

2005

Other Studies

12 other study(ies) available for pyrroles and Cancer of Nasopharynx

ArticleYear
Sunitinib Induces NK-κB-dependent NKG2D Ligand Expression in Nasopharyngeal Carcinoma and Hepatoma Cells.
    Journal of immunotherapy (Hagerstown, Md. : 1997), 2017, Volume: 40, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma; Carcinoma, Hepatocellular; Coculture Techniques; Combined Modality Therapy; Cytotoxicity, Immunologic; Gene Expression; Hep G2 Cells; Humans; Immunologic Surveillance; Immunotherapy, Adoptive; Indoles; Killer Cells, Natural; Ligands; Liver Neoplasms; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; NF-kappa B; NK Cell Lectin-Like Receptor Subfamily K; Protein Kinase Inhibitors; Pyrroles; RNA, Small Interfering; Signal Transduction; Sunitinib

2017
Inhibition of fibroblast growth factor receptor with AZD4547 mitigates juvenile nasopharyngeal angiofibroma.
    International forum of allergy & rhinology, 2017, Volume: 7, Issue:10

    Topics: Angiofibroma; Antineoplastic Agents; Benzamides; Cell Movement; Cell Proliferation; Cells, Cultured; Fibroblasts; Human Umbilical Vein Endothelial Cells; Humans; Indoles; Nasopharyngeal Neoplasms; Piperazines; Pyrazoles; Pyrroles; Receptors, Fibroblast Growth Factor; Receptors, Vascular Endothelial Growth Factor

2017
Famitinib enhances nasopharyngeal cancer cell radiosensitivity by attenuating radiation-induced phosphorylation of platelet-derived growth factor receptor and c-kit and inhibiting microvessel formation.
    International journal of radiation biology, 2015, Volume: 91, Issue:9

    Topics: Animals; Carcinoma; Cell Line, Tumor; Female; Humans; Indoles; Mice; Mice, Nude; Microvessels; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neovascularization, Pathologic; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrroles; Radiation Tolerance; Receptor, Platelet-Derived Growth Factor beta; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays

2015
Preclinical evaluation of sunitinib as single agent or in combination with chemotherapy in nasopharyngeal carcinoma.
    Investigational new drugs, 2011, Volume: 29, Issue:6

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Female; Humans; Indoles; Mice; Mice, Nude; Nasopharyngeal Neoplasms; Protein Kinase Inhibitors; Pyrroles; Sunitinib; Taxoids; Xenograft Model Antitumor Assays

2011
Role of sorafenib and sunitinib in the induction of expressions of NKG2D ligands in nasopharyngeal carcinoma with high expression of ABCG2.
    Journal of cancer research and clinical oncology, 2011, Volume: 137, Issue:5

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzenesulfonates; Cell Line, Tumor; Cytotoxicity, Immunologic; Drug Resistance, Neoplasm; GPI-Linked Proteins; Humans; Immunomagnetic Separation; Immunotherapy, Adoptive; Indoles; Intercellular Signaling Peptides and Proteins; Killer Cells, Natural; Linear Models; Nasopharyngeal Neoplasms; Neoplasm Proteins; Niacinamide; Phenylurea Compounds; Pyridines; Pyrroles; Reverse Transcriptase Polymerase Chain Reaction; Sorafenib; Sunitinib

2011
Hemorrhage caused by antiangiogenic therapy within previously irradiated areas: expected consequence of tumor shrinkage or a warning for antiangiogenic agents combined to radiotherapy?
    Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:6

    Topics: Antineoplastic Agents; Carcinoma; Female; Hematemesis; Hemoptysis; Humans; Indoles; Male; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Pyrroles; Sunitinib

2011
[The effect and mechanism of SU11248 on proliferation of nasopharyngeal carcinoma cell line CNE-2].
    Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology, 2013, Volume: 29, Issue:1

    Topics: Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cyclin G1; Cyclin-Dependent Kinase Inhibitor p27; Gene Expression Regulation, Neoplastic; Humans; Indoles; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Pyrroles; RNA, Messenger; Sunitinib

2013
Combination of thiol antioxidant Silibinin with Brostallicin is associated with increase in the anti-apoptotic protein Bcl-2 and decrease in caspase 3 activity.
    Cancer letters, 2006, Jul-08, Volume: 238, Issue:1

    Topics: Acetylcysteine; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Caspases; Cell Line, Tumor; Down-Regulation; Drug Antagonism; Drug Screening Assays, Antitumor; Enzyme Activation; Guanidines; Humans; Nasopharyngeal Neoplasms; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Signal Transduction; Silybin; Silymarin; Sulfhydryl Compounds; Up-Regulation

2006
Makaluvamines vary in ability to induce dose-dependent DNA cleavage via topoisomerase II interaction.
    Anti-cancer drugs, 1999, Volume: 10, Issue:1

    Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; DNA; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Enzyme Inhibitors; Etoposide; Humans; Mice; Mice, Nude; Nasopharyngeal Neoplasms; Pyrroles; Quinolones; Topoisomerase II Inhibitors

1999
Makaluvamine P, a new cytotoxic pyrroloiminoquinone from Zyzzya cf. fuliginosa.
    Journal of natural products, 2001, Volume: 64, Issue:10

    Topics: Animals; Antineoplastic Agents; Australia; Enzyme Inhibitors; Humans; KB Cells; Magnetic Resonance Spectroscopy; Mass Spectrometry; Molecular Structure; Nasopharyngeal Neoplasms; Porifera; Pyrroles; Quinolones; Toxicity Tests; Tumor Cells, Cultured; Xanthine Oxidase

2001
[Research on antineoplastic substances. LI. Derivatives of benzo(f)-pyrrolo-(1,2-a)-quinoxaline and naphtho-(2,1-e)-pyrrolo-(2,1-c)-as-triazine: synthesis and cytostatic and cytotoxic activity].
    Il Farmaco; edizione scientifica, 1973, Volume: 28, Issue:4

    Topics: Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Cell Line; Cells, Cultured; Culture Media; Humans; Mouth Neoplasms; Nasopharyngeal Neoplasms; Pyrroles; Quinoxalines; Structure-Activity Relationship; Triazines

1973
[Research on substances with antineoplastic activity. LVI. Anthramycin and analogues. V. Synthesis of derivatives of 7,8-dimethoxy and 7,8-methylendioxy-5H-pyrrolo(2,1-c)(1,4)benzodiazepine].
    Il Farmaco; edizione scientifica, 1974, Volume: 29, Issue:6

    Topics: Acrylamides; Antibiotics, Antineoplastic; Azepines; Benzazepines; Benzodiazepinones; Carcinoma, Squamous Cell; Culture Media; Humans; In Vitro Techniques; Nasopharyngeal Neoplasms; Pyrroles

1974